Ansätze der Biogerontologie
Reference43 articles.
1. Ayyadevara, Srinivas/Alla, Ramani/Thaden, John J./Shmookler Reis, Robert J.: Remarkable longevity and stress resistance of nematode PI3K-null mutants. In: Aging Cell 7/1 (2008), 13–22.
2. Bartke, Andrzej/Sun, Liou Y./Longo, Valter: Somatotropic signaling: trade-offs between growth, reproductive development, and longevity. In: Physiological Reviews 93/2 (2013), 571–598. Barzilai, Nir: Elder pharmacology. Studying and treating the chronic diseases associated with aging needs serious revamping (2014). In: http://www.the-scientist.com/critic-at-large/elder-pharmacology-38202 (22.8.2018).
3. Blagosklonny, Mikhail V.: Aging and immortality: quasiprogrammed senescence and its pharmacologic inhibition. In: Cell Cycle 5/18 (2006), 2087–2102.
4. Blagosklonny, Mikhail V.: Aging: ROS or TOR. In: Cell Cycle 7/21 (2008), 3344–3354.
5. Blagosklonny, Mikhail V.: Revisiting the antagonistic pleiotropy theory of aging: TOR-driven program and quasiprogram. In: Cell Cycle 9/16 (2010), 3151–3156.